Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

Key Takeaways U.S. equities rose at midday Tuesday on optimism that the new tariffs threatened by President Trump won't be as ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Investing.com -- Moderna , Inc. (NASDAQ: MRNA) shares surged 14% following remarks by Oracle (NYSE: ORCL) Chairman Larry ...

Moderna stock opened at $38.50 on Thursday. Moderna has a 52 week low of $31.94 and a 52 week high of $170.47. The stock has a 50-day moving average price of $40.52 and a 200 day moving average ...

The stocks listed here have all been struggling due to weak demand. They are cheap-looking buys that investors haven't been ...